Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetees mellitus

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 11, 2000, Pages 4053-4059

  Shah, Pankaj ^a   Vella, Adrian ^a   Basu, Ananda ^a   Basu, Rita ^a   Schwenk, W Frederick ^a   Rizza, Robert A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; GLUCOSE; INSULIN; URIDINE DIPHOSPHATE GLUCOSE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCAGON RELEASE; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; GLYCOGENOLYSIS; HORMONAL REGULATION; HORMONE ACTION; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

BLOOD GLUCOSE; C-PEPTIDE; DIABETES MELLITUS, TYPE 2; FEMALE; GALACTOSE; GLUCAGON; GLYCOGEN; HUMAN GROWTH HORMONE; HUMANS; HYPERGLYCEMIA; INFUSIONS, INTRAVENOUS; INSULIN; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD;

EID: 0034524938     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.11.4053     Document Type: Article

References (56)

1. Contribution to postprandial hyperglycemia and effect on initial splanchnic glucose clearance of hepatic glucose cycling in glucose-intolerant or NIDDM patients
2. Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM
3. Influence of maturity-onset diabetes on splanchnic glucose balance after oral glucose ingestion
4. Abnormal α-cell function in diabetes
5. Abnormal transient rise in hepatic glucose production after oral glucose in non-insulin-dependent diabetic subjects
6. Impaired postprandial glucose utilization in non-insulin-dependent diabetes mellitus
7. Gastric inhibitory polypeptide responses and glucose turnover rates after natural meals in type II diabetic patients
8. Documentation of hyperglucagonemia throughout the day in nonobese and obese patients with noninsulin-dependent diabetes mellitus
9. Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine
10. Impact of lack of suppression of glucagon on glucose tolerance in humans
11. Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM
12. Effects of glucagon on postprandial carbohydrate metabolism in nondiabetic humans
13. Effects of a change in the pattern of insulin delivery on carbohydrate tolerance in diabetic and nondiabetic humans in the presence of differing degrees of insulin resistance
14. Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes
15. Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus
16. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians
17. Insulin deficiency and insulin resistance in type 2 (non-insulin-dependent) diabetes: Quantitative contributions of pancreatic and peripheral responses to glucose homeostasis
18. Insulin secretion and action in noninsulin-dependent diabetes mellitus. Is insulin resistance secondary to hypoinsulinemia?
19. Impaired basal glucose effectiveness in NIDDM: Contribution of defects in glucose disappearance and production, measured using an optimized minimal model independent protocol
20. Role of glucose effectiveness in the determination of glucose tolerance
21. Assessment of insulin action and glucose effectiveness in diabetic and non-diabetic humans
22. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: Results of a 25-year follow-up study
23. Reduced glucose effectiveness as a feature of glucose intolerance: Evidence in elderly type-2 diabetic subjects
24. Alterations in non-insulin-mediated glucose uptake in the elderly patient with diabetes
25. Pathogenetic mechanisms of impaired glucose tolerance and type II diabetes in African-Americans. The significance of insulin secretion, insulin sensitivity, and glucose effectiveness
26. Hyperglucagonemia and blood glucose regulation in normal, obese and diabetic subjects
27. Effects of insulin on glucagon-stimulated glucose production in the conscious dog
28. Minimal increases in glucagon levels enhance glucose production in man with partial hypoinsulinemia
29. Transient hepatic response to glucagon in man: Role of insulin and hyperglycemia
30. Practical closed-loop insulin delivery. A system for the maintenance of overnight euglycemia and the calculation of basal insulin requirements in insulin-dependent diabetics
31. Improved counter-regulatory hormonal and symptomatic responses to hypoglycemia in patients with insulin-dependent diabetes mellitus after 3 months of less strict glycemic control
32. Hepatic glycogen accurately reflected by acetaminophen glucuronide in dogs refed after fasting
33. Quantitation of the pathways of hepatic glycogen formation on ingesting a glucose load
34. Quantitation of glycogen/glucose-1-P cycling in liver
35. Glycoconjugates as non-invasive probes of intrahepatic metabolism. I. Kinetics of label incorporation with evidence of a common precursor UDP-glucose pool for secreted glycoconjugates
36. Hepatic gluconeogenic fluxes and glycogen turnover during fasting in humans. A stable isotope study
37. Effects of glucose on hepatic conversion of aminonitrogen to urea in patients with cirrhosis: Relationship to glucagon
38. Abnormal meal carbohydrate disposition in insulin-dependent diabetes. Relative contributions of endogenous glucose production and initial splanchnic uptake and effect of intensive insulin therapy
39. Quantitation of measurement error with optimal segments: Basis for adaptive time course smoothing
40. Measurement of size of turnover rate of body glucose pool by the isotopic dilution method
41. Methods for assessment of the rate of onset and offset of insulin action during nonsteady state in humans
42. Rate of glucose entry into hepatic uridine diphosphoglucose by the direct pathway in fasted and fed states in normal humans
43. Glycoconjugates as noninvasive probes of intrahepatic metabolism. II. Application to measurement of plasma α1-add glycoprotein turnover during inflammation
44. Hepatic gluconeogenic fluxes and glycogen turnover during fasting in humans. A stable isotope study
45. Differential time course of glucagon's effect on glycogenolysis and gluconeogenesis in the conscious dog
46. Contribution of hepatic glycogenolysis to glucose production in humans in response to a physiological increase in plasma glucagon concentration
47. Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: Evidence for a defect in haptic glucokinase activity
48. Assessment of hepatic sensitivity to glucagon in NIDDM: Use as a tool to estimate the contribution of the indirect pathway to nocturnal glycogen synthesis
49. Chronic and transitional regulation of gluconeogenesis and glyconeogenesis by insulin and glucagon in neonatal calf hepatocytes
50. Hormonal control of glycogenolysis, gluconeogenesis in isolated rat liver cells
51. Physiological changes in circulating glucagon alter hepatic glucose disposition during portal glucose delivery
52. The roles of insulin and glucagon in the regulation of hepatic glycogen synthesis and turnover in humans
53. Glucagon is a primary controller of hepatic glycogenolysis and gluconeogenesis during muscular work
54. Portal and peripheral vein immunoreactive glucagon concentrations after arginine or glucose infusions
55. Transhepatic glucagon gradients in man: Evidence for glucagon extraction by human liver
56. Effects of hepatic glycogen content on hepatic insulin action in humans: Alteration in the relative contributions of glycogenolysis and gluconeogenesis to endogenous glucose production